Blade Therapeutics Funding & Investors
Blade Therapeutics, Inc. operates as a biopharmaceutical company for treating fibrosis. The Company offers screening, drug discovery and development, tissue replacement, and fibrotic disease management. Blade Therapeutics conducts its business in the United States.
blademed.comTotal Amount Raised: $51,500,000
Blade Therapeutics Funding Rounds
Series B
$45,000,000
Series B Investors
Deerfield ManagementPfizer Venture InvestmentsBristol-Myers SquibbMPM CapitalOUP (Osage University Partners)Novartis InstitutesSeries A
$6,500,000
Series A Investors
MPM CapitalOUP (Osage University Partners)
Funding info provided by Diffbot.